These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6392599)

  • 1. Antimicrobial susceptibility of Serratia marcescens isolated from clinical materials.
    Igari J; Oguri T; Kosakai N
    Jpn J Antibiot; 1984 Sep; 37(9):1625-30. PubMed ID: 6392599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [O-serotypes, biochemical properties and antimicrobial susceptibilities of Serratia marcescens isolated from clinical specimens (2nd report)].
    Marumo K; Takeuchi T; Aoki Y
    Rinsho Byori; 1990 Sep; 38(9):1077-82. PubMed ID: 1700174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [O-serotypes, biotypes and antimicrobial susceptibilities of Serratia marcescens isolates from clinical specimens: 4th report].
    Marumo K; Nakamura Y; Fukuda S
    Rinsho Byori; 1995 Nov; 43(11):1140-6. PubMed ID: 8551678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
    Kawakami Y; Okimura Y; Horiuchi N; Kanai M
    Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
    Markowitz SM; Sibilla DJ
    Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibilities and bacteriological characteristics of bovine Pseudomonas aeruginosa and Serratia marcescens isolates from mastitis.
    Ohnishi M; Sawada T; Hirose K; Sato R; Hayashimoto M; Hata E; Yonezawa C; Kato H
    Vet Microbiol; 2011 Dec; 154(1-2):202-7. PubMed ID: 21783330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of clinical isolates of Serratia marcescens.
    Alvarez JS; Regueiro B; Garrido MJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):523-4. PubMed ID: 391150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
    Traub WH
    Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). III. Secular changes in susceptibility].
    Kosaki N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1989 Oct; 42(10):2189-312. PubMed ID: 2607604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiological evaluation of Serratia marcescens isolates in one Japanese hospital during the two years from April 1997 to March 1999].
    Marumo K; Nakamura Y; Togashi M
    Rinsho Byori; 2000 Oct; 48(10):960-5. PubMed ID: 11215111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance patterns of clinical isolates of Serratia marcescens.
    Cooksey RC; Bannister ER; Farrar WE
    Antimicrob Agents Chemother; 1975 Apr; 7(4):396-9. PubMed ID: 1096799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
    Wilfert JN; Barrett FF; Ewing WH; Finland M; Kass EH
    Appl Microbiol; 1970 Feb; 19(2):345-52. PubMed ID: 4314379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1991). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Oct; 48(10):1394-421. PubMed ID: 8544337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1990 Jun; 43(6):968-1136. PubMed ID: 2122041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
    Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.